The research programs of the Division of Hematology and Oncology focus on discovering new approaches to diagnose and the prevention and treatment of cancers that can be translated to the clinic. Many of our faculty are recognized leaders nationally and internationally in cancer research. Our laboratory-based research scientists and clinical researchers actively engage in research efforts as members of the Vanderbilt-Ingram Cancer Center (VICC).

The Division of Hematology and Oncology, one of 13 academic divisions in the Department of Medicine, has figured prominently in the success of the VICC and the rapid growth of its clinical and research portfolio. In 2016, the Vanderbilt Department of Medicine ranked 3rd in NIH research funding among all U.S. medical school departments of medicine.

Today, the Division of Hematology and Oncology is comprised of over 80 full-time faculty members who maintain active research programs with more than $7.5 million in annual peer-reviewed grant support and more than $25 million in annual non-peer-reviewed research support.


Patrick Hu
Patrick Hu, MD, PhD, is an Associate Professor of Medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center and a member of the Cancer Cell Biology Research Program at Vanderbilt Ingram Cancer Center.


The Vanderbilt-Ingram Cancer Center is comprised of eight research programs that build on historical strengths at Vanderbilt as well as represent new opportunities for discovery and development.

The eight Vanderbilt-Ingram Research Programs are: 

In addition, there are a number of shared resources that provide our investigators access to frontier technology that would otherwise be impractical to set up in individual laboratories. These resources provide our faculty access to state-of-the-art instrumentation and methodology that includes:

For detailed information about the seven VICC Research Programs and Shared Resources, visit VICC.